Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > hugh is in Milan today for instance !EuroPCR 2024 GEHC to ?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Post by jopatcloon May 18, 2024 12:54pm
73 Views
Post# 36047363

hugh is in Milan today for instance !EuroPCR 2024 GEHC to ?

hugh is in Milan today for instance !EuroPCR 2024 GEHC to ?

EuroPCR 2024 interesting good comment cardinal
hugh is in Milan today for instance and Bob H is meeting
with people on their timelines.

Monday Good new,Interesting EuroPCR 2024 - “Imaging is the eyes of the Heart Team!” Hello from Angiopro!
 
The transformation of interventional cardiology continues to evolve at a rapid rate - driven by advancements in structural heart, electrophysiology and the application of AI, among other factors.

This year at EuroPCR we showcased how we’re bringing the best of new and emerging technologies into our core Allia IGS Platform to enable a more seamless operating experience for clinicians and better outcomes for their patients.

At the of intervention is an exciting place to be as we look to transform the delivery of health care!

EuroPCR Cardiology HealthcareTechnology

The transformation of interventional cardiology continues to evolve at a rapid rate - driven by advancements in structural heart, electrophysiology and the application of AI, among other factors.

This year at EuroPCR we showcased how we’re bringing the best of new and emerging technologies into our core Allia IGS Platform to enable a more seamless operating experience for clinicians and better outcomes for their patients.

At the of intervention is an exciting place to be as we look to transform the delivery of health care!

EuroPCR Cardiology HealthcareTechnology

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities